BioNexus Gene Lab (BGLC) Earnings Date, Estimates & Call Transcripts

$0.59
0.00 (0.00%)
(As of 04/26/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

BGLC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BGLC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BGLC Earnings Date and Information

BioNexus Gene Lab has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

BioNexus Gene Lab Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
11/20/2023Q3 2023-($0.02)($0.02)($0.02)-$2.55 million

BioNexus Gene Lab Earnings - Frequently Asked Questions

When is BioNexus Gene Lab's earnings date?

BioNexus Gene Lab has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on BGLC's earnings history.

How much revenue does BioNexus Gene Lab generate each year?

BioNexus Gene Lab (NASDAQ:BGLC) has a recorded annual revenue of $9.77 million.

How much profit does BioNexus Gene Lab generate each year?

BioNexus Gene Lab (NASDAQ:BGLC) has a recorded net income of -$2.63 million. BGLC has generated -$0.02 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:BGLC) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners